NDC 0781-3003-70
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3003
- Requested NDC
- 0781-3003-70
- Package NDCs from labels
- 0781-3003-70
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3003-70 | ML - Milliliter | 0781-3003 | c5bea606-8733-403f-9922-27e7cac36f13 | 1 | 2012-07-24 |
| 0781-3003-75 | ML - Milliliter | 0781-3003 | 05b8546b-a7c0-4026-a387-1c23686a3b14 | 1 | 2012-07-24 |
| 0781-3003-92 | ML - Milliliter | 0781-3003 | 733f9055-a903-4ed2-b48c-7d44cb248059 | 1 | 2012-07-24 |
| 0781-3003-95 | ML - Milliliter | 0781-3003 | a6c41535-8339-4e65-88d7-dcfa7adbfaed | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Sandoz Inc | cf2f4b95-0327-499a-a5a3-51b1bdef68c5 | 2024-12-30 | Warnings, Adverse reactions | Sandoz Inc |
| Flumazenil | FLUMAZENIL | Medical Purchasing Solutions, LLC | 28f31b54-ff30-fd0d-e063-6394a90afc18 | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | Flumazenil FLUMAZENIL |
| Butalbital, aspirin, and caffeine | BUTALBITAL, ASPIRIN, AND CAFFEINE | Sandoz Inc | 0e5e3842-fc6c-4a24-8e5c-522701f7c291 | 2024-12-02 | Warnings, Adverse reactions | Sandoz Inc |
| Infuvite Pediatric | MULTIPLE VITAMINS INJECTION | Sandoz Inc | 6d06546e-8b0a-4490-82d9-397bd902a044 | 2024-11-20 | Warnings, Adverse reactions | Sandoz Inc |
| CIPRO HC | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | Sandoz Inc | b26594a3-2adf-4954-8be0-5bd6f8de9671 | 2024-11-08 | Warnings, Adverse reactions | Sandoz Inc |
| Infuvite Adult | MULTIPLE VITAMINS INJECTION | Sandoz Inc | 14c7bfc5-07e8-400f-b8ff-5e4794dd2805 | 2024-11-06 | Warnings, Adverse reactions | Sandoz Inc |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Sandoz Inc | 7f2e3c46-9f39-45e7-99a9-64cc4f6f649d | 2024-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | c2908a44-1da4-4885-ae5a-23f69189d91a | 2024-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | b371e1a5-1fef-4df2-8940-c4fc02b9e2f0 | 2024-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| cisatracurium besylate | CISATRACURIUM BESYLATE | Sandoz Inc | 2ee0358e-2cce-40d3-9fcf-1b9088815c98 | 2024-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| cisatracurium besylate | CISATRACURIUM BESYLATE | Sandoz Inc | 291a55dd-ab45-4660-b513-4ecb729eb051 | 2024-10-31 | Warnings, Adverse reactions | Sandoz Inc |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | 9b682c66-61c6-4ade-baf4-9d68911a16b8 | 2024-10-30 | Warnings, Adverse reactions | Sandoz Inc |
| Pirfenidone | PIRFENIDONE | Sandoz Inc | 945d4337-7d18-4d84-807b-8ae13750c76d | 2024-10-30 | Warnings, Adverse reactions | Sandoz Inc |
| Azacitidine | AZACITIDINE | Sandoz Inc | 7f89fcbd-d3f4-4112-8733-69baea41255e | 2024-10-24 | Warnings, Adverse reactions | Sandoz Inc |
| Apraclonidine | APRACLONIDINE | Sandoz Inc | 04ad82af-e7ba-4f40-a120-be9d33cf0c7b | 2024-10-02 | Warnings, Adverse reactions | Sandoz Inc |
| Eribulin Mesylate | ERIBULIN MESYLATE | Sandoz Inc | d122f0a4-aff7-49f7-8cf1-06bc2883ad43 | 2024-10-02 | Warnings, Adverse reactions | Sandoz Inc |
| tamsulosin hydrochloride | TAMSULOSIN HYDROCHLORIDE | Sandoz Inc | fb120098-b007-4a33-80b8-b7279c7668ee | 2024-09-30 | Warnings, Adverse reactions | Sandoz Inc |
| Zolpidem Tartrate | ZOLPIDEM TARTRATE | Sandoz Inc | 0553e26c-f2aa-43aa-adf9-6eb951a501d3 | 2024-09-10 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Aprepitant | APREPITANT | Sandoz Inc | f58b8944-93ee-4be1-a238-cc0061ddd93a | 2024-09-09 | Warnings, Adverse reactions | Sandoz Inc |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | b1cb1314-d3e0-4b44-a1df-de14c32e8cc6 | 2024-08-23 | Warnings, Adverse reactions | Sandoz Inc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.